These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32323126)

  • 1. Stability Test of PACAP in Eye Drops.
    Kovacs AK; Atlasz T; Werling D; Szabo E; Reglodi D; Toth GK
    J Mol Neurosci; 2021 Aug; 71(8):1567-1574. PubMed ID: 32323126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular Delivery of PACAP1-27 Protects the Retina From Ischemic Damage in Rodents.
    Werling D; Reglodi D; Banks WA; Salameh TS; Kovacs K; Kvarik T; Vaczy A; Kovacs L; Mayer F; Danyadi B; Lokos E; Tamas A; Toth G; Biro Z; Atlasz T
    Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6683-6691. PubMed ID: 27936470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passage through the Ocular Barriers and Beneficial Effects in Retinal Ischemia of Topical Application of PACAP1-38 in Rodents.
    Werling D; Banks WA; Salameh TS; Kvarik T; Kovacs LA; Vaczy A; Szabo E; Mayer F; Varga R; Tamas A; Toth G; Biro Z; Atlasz T; Reglodi D
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoprotective Effects of PACAP Eye Drops in Microbead-Induced Glaucoma Model in Rats.
    Szabo E; Patko E; Vaczy A; Molitor D; Csutak A; Toth G; Reglodi D; Atlasz T
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoprotective Effects of TAT-Bound Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Polypeptide.
    Atlasz T; Werling D; Song S; Szabo E; Vaczy A; Kovari P; Tamas A; Reglodi D; Yu R
    J Mol Neurosci; 2019 Jul; 68(3):397-407. PubMed ID: 30542799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Novel tear secretion system - the effect and the mechanism of PACAP on tear secretion].
    Nakamachi T
    Nihon Yakurigaku Zasshi; 2018; 151(6):232-238. PubMed ID: 29887571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Backup Mechanisms Maintain PACAP/VIP-Induced Arterial Relaxations in Pituitary Adenylate Cyclase-Activating Polypeptide-Deficient Mice.
    Ivic I; Fulop BD; Juhasz T; Reglodi D; Toth G; Hashimoto H; Tamas A; Koller A
    J Vasc Res; 2017; 54(3):180-192. PubMed ID: 28490016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PACAP suppresses dry eye signs by stimulating tear secretion.
    Nakamachi T; Ohtaki H; Seki T; Yofu S; Kagami N; Hashimoto H; Shintani N; Baba A; Mark L; Lanekoff I; Kiss P; Farkas J; Reglodi D; Shioda S
    Nat Commun; 2016 Jun; 7():12034. PubMed ID: 27345595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Therapeutic Role of Pituitary Adenylate Cyclase-Activating Polypeptide for Dry Eye Disease.
    Hirabayashi T; Shibato J; Kimura A; Yamashita M; Takenoya F; Shioda S
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pituitary adenylate cyclase activating polypeptide (PACAP) on the PKA-Bad-14-3-3 signaling pathway in glutamate-induced retinal injury in neonatal rats.
    Rácz B; Gallyas F; Kiss P; Tamás A; Lubics A; Lengvári I; Röth E; Tóth G; Hegyi O; Verzál Z; Fabricsek C; Reglódi D
    Neurotox Res; 2007 Sep; 12(2):95-104. PubMed ID: 17967733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective Effects of Pituitary Adenylate-Cyclase-Activating Polypeptide on Retinal Vasculature and Molecular Responses in a Rat Model of Moderate Glaucoma.
    Patko E; Szabo E; Vaczy A; Molitor D; Tari E; Li L; Csutak A; Toth G; Reglodi D; Atlasz T
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PACAP and its receptors in cranial arteries and mast cells.
    Jansen-Olesen I; Hougaard Pedersen S
    J Headache Pain; 2018 Feb; 19(1):16. PubMed ID: 29460121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleiotropic and retinoprotective functions of PACAP.
    Shioda S; Takenoya F; Wada N; Hirabayashi T; Seki T; Nakamachi T
    Anat Sci Int; 2016 Sep; 91(4):313-24. PubMed ID: 27324639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Protective Role of PAC1-Receptor Agonist Maxadilan in BCCAO-Induced Retinal Degeneration.
    Vaczy A; Reglodi D; Somoskeoy T; Kovacs K; Lokos E; Szabo E; Tamas A; Atlasz T
    J Mol Neurosci; 2016 Oct; 60(2):186-94. PubMed ID: 27566170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel stable PACAP analogs with potent activity towards the PAC1 receptor.
    Bourgault S; Vaudry D; Botia B; Couvineau A; Laburthe M; Vaudry H; Fournier A
    Peptides; 2008 Jun; 29(6):919-32. PubMed ID: 18353507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary adenylate cyclase-activating polypeptides, PACAP-38 and PACAP-27, regulation of sympathetic neuron catecholamine, and neuropeptide Y expression through activation of type I PACAP/VIP receptor isoforms.
    Braas KM; May V
    Ann N Y Acad Sci; 1996 Dec; 805():204-16; discussion 217-8. PubMed ID: 8993404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The amidated PACAP
    Lamine A; Poujol de Molliens M; Létourneau M; Hébert TE; Vaudry D; Fournier A; Chatenet D
    Biochim Biophys Acta Gen Subj; 2019 Nov; 1863(11):129410. PubMed ID: 31401178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary adenylate cyclase-activating polypeptide (PACAP) induces relaxations of peripheral and cerebral arteries, which are differentially impaired by aging.
    Vamos Z; Ivic I; Cseplo P; Toth G; Tamas A; Reglodi D; Koller A
    J Mol Neurosci; 2014 Nov; 54(3):535-42. PubMed ID: 24939249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary adenylate cyclase-activating polypeptide: focus on structure-activity relationships of a neuroprotective Peptide.
    Bourgault S; Vaudry D; Dejda A; Doan ND; Vaudry H; Fournier A
    Curr Med Chem; 2009; 16(33):4462-80. PubMed ID: 19835562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects.
    Atlasz T; Szabadfi K; Kiss P; Racz B; Gallyas F; Tamas A; Gaal V; Marton Z; Gabriel R; Reglodi D
    Ann N Y Acad Sci; 2010 Jul; 1200():128-39. PubMed ID: 20633141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.